Evidence map›Paper›PMID 41346478›Full record

ArticleAlzheimer's & dementia. Behavior & socioeconomics of aging2025

Higher neighborhood deprivation is associated with accelerated disease progression in behavioral-variant frontotemporal degeneration.

Rory Boyle, Nadia Dehghani, Sheina Emrani, Anil R Wadhwani, Melanie Matyi, Katheryn A Q Cousins, Emma Rhodes, Brian Nelson, Shana D Stites, Sharon X Xie and 6 more

Abstract read
In one paragraph

Article in Alzheimer's & dementia. Behavior & socioeconomics of aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Rory BoylePenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Nadia DehghaniPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sheina EmraniPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Anil R WadhwaniPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Melanie MatyiPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Katheryn A Q CousinsPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Emma RhodesPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Brian NelsonPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Shana D StitesDepartment of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Sharon X XieDepartment of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Laynie DratchPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Vivianna M Van DeerlinDepartment of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Allison SnyderPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
David J IrwinPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Corey T McMillanPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lauren MassimoPenn Frontotemporal Degeneration Center, Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID 0000-0002-3407-7335

Funding

Research Education ComponentP30AG072979 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DAVID A WOLK · 2021 to 2026
$24.8M
Technology Identification and Training CoreP30AG073105 · NIA · UNIVERSITY OF PENNSYLVANIA · PI DEMIRIS, GEORGE, KARLAWISH, JASON H · 2021 to 2025
$21.2M
Understanding Environmental Contributions to Heterogeneity in bvFTD.P01AG066597 · NIA · UNIVERSITY OF PENNSYLVANIA · PI David John Irwin, Corey T McMillan · 2020 to 2026
$18.8M
STATISTICAL DATA ENCLAVE COREP30AG012836 · NIA · UNIVERSITY OF PENNSYLVANIA · PI COE, NORMA B · 1999 to 2024
$14.0M
Multidimensional Approaches to Understanding Consequences and Mechanisms of Apathy in Frontotemporal DegenerationR01AG076832 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Lauren M Massimo · 2022 to 2026
$2.6M
Pathology-guided biofluid biomarker strategies for classification and progression of frontotemporal lobar degeneration (FTLD)R01AG087258 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Katheryn Alexandra Quilico Cousins · 2024 to 2026
$2.4M
Study of Cognitive Symptoms and Future Time Perspective in Preclinical Alzheimer's DiseaseK23AG065442 · NIA · UNIVERSITY OF PENNSYLVANIA · PI STITES, SHANA D. · 2020 to 2024
$886k
Digital monitoring of autonomic activity to detect empathy loss in behavioral variant frontotemporal dementiaK23AG083124 · NIA · UNIVERSITY OF PENNSYLVANIA · PI Emma Rhodes · 2023 to 2026
$652k
NIA NIH HHS K23 AG065442NIA NIH HHS K23 AG083124NIA NIH HHS P01 AG066597NIA NIH HHS P30 AG012836NIA NIH HHS P30 AG072979NIA NIH HHS P30 AG073105NIA NIH HHS R01 AG076832NIA NIH HHS R01 AG087258
6 · The paper itself

Abstract

introductionNeighborhood deprivation is associated with shorter survival, cognitive impairment, and neurodegeneration in aging and Alzheimer's disease. However, the association of neighborhood deprivation with disease progression in behavioral-variant frontotemporal degeneration (bvFTD) is unknown.

methodsWe examined associations between tertiles of neighborhood deprivation, using the Area Deprivation Index (ADI), and survival in 311 individuals clinically diagnosed with bvFTD from the Penn FTD Center. In a subset (

resultsCompared to adults living in the least deprived neighborhoods, those living in the most deprived neighborhoods showed shorter survival after symptom onset and faster decline in global cognition, executive and language functions, independent of genetic risk. DISCUSSION: Living in more deprived neighborhoods was associated with an accelerated disease course in bvFTD, highlighting an important socioeconomic disparity in disease prognosis. CLINICAL TRIAL REGISTRATION INFORMATION: N/A.

Indexed as

Area Deprivation Indexbehavioral-variant frontotemporal degenerationbrain health equitycognitive declineexecutive functionfrontotemporal degenerationneighborhood deprivationreserveresiliencesocial and structural determinants of healthsocioeconomic status

Identifiers

PMID41346478
PMCPMC12674657

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.